Andrea joined LSP as an analyst in 2021. Andrea is part of the LSP Dementia fund focused on all stages of dementia and other neurodegenerative diseases drug and medtech developments and is involved in all stages of the investment process, particularly on deal flow screening and scientific due diligence.

Before joining LSP, Andrea worked as a senior consultant and team leader at FFUND, a boutique consultancy working with start-ups in health and life sciences. Andrea supported these companies with non-dilutive and dilutive funding applications, business strategy, and consortium building while coordinating a team of consultants and interns working in parallel projects.

Andrea received her PhD from the University of Groningen in The Netherlands in behavioural and cognitive neurosciences. Her research focused on the relation between interval timing and neurodegenerative processes, as well as on the interaction of stress and social environment on brain function and behaviour. She worked in several translational models of these phenomena, from fruit flies to humans. Her research and innovative method are published in several renown journals. Prior to her PhD, Andrea became a Medical Doctor at the National and Autonomous University of Mexico (Universidad National Autónoma de México, UNAM), during which she conducted research with animal Alzheimer models and clinical Multiple Sclerosis patients. Andrea lives in Haarlem with her husband and over 40 houseplants.